326 related articles for article (PubMed ID: 37822610)
1. Don't eat me/eat me signals as a novel strategy in cancer immunotherapy.
Khalaji A; Yancheshmeh FB; Farham F; Khorram A; Sheshbolouki S; Zokaei M; Vatankhah F; Soleymani-Goloujeh M
Heliyon; 2023 Oct; 9(10):e20507. PubMed ID: 37822610
[TBL] [Abstract][Full Text] [Related]
2. Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.
Kelley SM; Ravichandran KS
EMBO Rep; 2021 Jun; 22(6):e52564. PubMed ID: 34041845
[TBL] [Abstract][Full Text] [Related]
3. Understanding the regulation of "Don't Eat-Me" signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy.
Karizak AZ; Salmasi Z; Gheibihayat SM; Asadi M; Ghasemi Y; Tajbakhsh A; Savardashtaki A
J Cancer Res Clin Oncol; 2023 Jan; 149(1):511-529. PubMed ID: 36342520
[TBL] [Abstract][Full Text] [Related]
4. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
5. Exploiting Phagocytic Checkpoints in Nanomedicine: Applications in Imaging and Combination Therapies.
Landry MR; Walker JM; Sun C
Front Chem; 2021; 9():642530. PubMed ID: 33748077
[TBL] [Abstract][Full Text] [Related]
6. The Combination of Anti-CD47 Antibody with CTLA4 Blockade Enhances Anti-Tumor Immunity in Non-Small Cell Lung Cancer via Normalization of Tumor Vasculature and Reprogramming of the Immune Microenvironment.
Zhuang Z; Zhou J; Qiu M; Li J; Lin Z; Yi H; Liu X; Huang C; Tang B; Liu B; Li X
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398223
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy.
Luo JQ; Liu R; Chen FM; Zhang JY; Zheng SJ; Shao D; Du JZ
ACS Nano; 2023 May; 17(10):8966-8979. PubMed ID: 37133900
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation.
Du R; Tripathi S; Najem H; Brat DJ; Lukas RV; Zhang P; Heimberger AB
Cells; 2024 May; 13(10):. PubMed ID: 38786045
[TBL] [Abstract][Full Text] [Related]
9. SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal.
Yu J; Li S; Chen D; Liu D; Guo H; Yang C; Zhang W; Zhang L; Zhao G; Tu X; Peng L; Liu S; Bai X; Song Y; Jiang Z; Zhang R; Tian W
J Hematol Oncol; 2022 Nov; 15(1):167. PubMed ID: 36384978
[TBL] [Abstract][Full Text] [Related]
10. Breaking the 'don't eat me' signal: in silico design of CD47-directed peptides for cancer immunotherapy.
Laddha K; Sobhia ME
Mol Divers; 2023 Sep; ():. PubMed ID: 37759140
[TBL] [Abstract][Full Text] [Related]
11. A combined "eat me/don't eat me" strategy based on extracellular vesicles for anticancer nanomedicine.
Belhadj Z; He B; Deng H; Song S; Zhang H; Wang X; Dai W; Zhang Q
J Extracell Vesicles; 2020 Aug; 9(1):1806444. PubMed ID: 32944191
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy.
Zhang YR; Luo JQ; Zhang JY; Miao WM; Wu JS; Huang H; Tong QS; Shen S; Leong KW; Du JZ; Wang J
Small; 2020 Nov; 16(46):e2004240. PubMed ID: 33107142
[TBL] [Abstract][Full Text] [Related]
13. An Acquired and Endogenous Glycocalyx Forms a Bidirectional "Don't Eat" and "Don't Eat Me" Barrier to Phagocytosis.
Imbert PRC; Saric A; Pedram K; Bertozzi CR; Grinstein S; Freeman SA
Curr Biol; 2021 Jan; 31(1):77-89.e5. PubMed ID: 33096038
[TBL] [Abstract][Full Text] [Related]
14. Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma.
Sun J; Muz B; Alhallak K; Markovic M; Gurley S; Wang Z; Guenthner N; Wasden K; Fiala M; King J; Kohnen D; Salama NN; Vij R; Azab AK
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32012878
[TBL] [Abstract][Full Text] [Related]
15. The MHC class I-LILRB1 signalling axis as a promising target in cancer therapy.
Zhao J; Zhong S; Niu X; Jiang J; Zhang R; Li Q
Scand J Immunol; 2019 Nov; 90(5):e12804. PubMed ID: 31267559
[TBL] [Abstract][Full Text] [Related]
16. Improving nanochemoimmunotherapy efficacy by boosting "eat-me" signaling and downregulating "don't-eat-me" signaling with
Pang G; Wei S; Zhao J; Wang FJ
J Mater Chem B; 2023 Dec; 11(48):11562-11577. PubMed ID: 37982298
[TBL] [Abstract][Full Text] [Related]
17. The Phagocytic Code Regulating Phagocytosis of Mammalian Cells.
Cockram TOJ; Dundee JM; Popescu AS; Brown GC
Front Immunol; 2021; 12():629979. PubMed ID: 34177884
[TBL] [Abstract][Full Text] [Related]
18. The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.
Schürch CM; Forster S; Brühl F; Yang SH; Felley-Bosco E; Hewer E
Oncoimmunology; 2017; 7(1):e1373235. PubMed ID: 29296529
[TBL] [Abstract][Full Text] [Related]
19. Precise Delivery of Nanomedicines to M2 Macrophages by Combining "Eat Me/Don't Eat Me" Signals and Its Anticancer Application.
Tang Y; Tang Z; Li P; Tang K; Ma Z; Wang Y; Wang X; Li C
ACS Nano; 2021 Nov; 15(11):18100-18112. PubMed ID: 34751571
[TBL] [Abstract][Full Text] [Related]
20. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
